Personalized vaccines and public health genomics: Anticipating and monitoring the ELSIs

Current Pharmacogenomics and Personalized Medicine

Volumn 8, Issue 1, 2010, Pages 4-6

  Joly, Y ^a   McClellan, K A ^a   Knoppers, B M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CONFIDENTIALITY; ECONOMIC ASPECT; EDITORIAL; ETHICS; GENETICS; GENOMICS; HEALTH SERVICE; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; PATENT; PERSONAL NEEDS; PUBLIC HEALTH; SOCIAL ASPECT; TREATMENT PLANNING;

EID: 77950208273     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111008010004     Document Type: Editorial

References (13)

1. Poland GA. Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin Pharmacol Ther 2007; 82: 623-626
2. Burke W, Khoury MJ, Stewart A, et al. The path from genome-based research to population health: Development of an international public health genomics network. Genet Med 2006; 8: 451-458
3. Khoury MJ. Dr. Muin J. Khoury discusses the future of public health genomics and why it matters for personalized medicine and global health. Curr Pharmacogenomics Person Med 2009; 7: 158-163
4. Poland GA, Ovsyannikova IG, Jacobson RM. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008; 8: 1659-1667
5. Seib KL, Dougan G, Rappuoli R. The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet 2009; 5(10): p. e1000612.
6. Poland GA, Ovsyannikova G, Jacobson RM. Vaccine immuno-genetics: bedside to bench to population. Vaccine 2008; 26: 6183-6188
7. Ovsyannikova IG, Dhiman N, Jacobson RM, et al. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Rev Vaccines 2006; 5: 33-43.
8. Joly Y, Sillon G, Silverstein T, et al. Pharmacogenomics: Don't forget the children. Curr Pharmacogenomics Person Med 2008; 6: 77-84.
9. Daar AS, Thorsteinsdóttir H, Martin DK, et al. Top ten bio-technologies for improving health in developing countries. Nat Genet 2002; 32: 229-232
10. Anonymous [Editorial]. Pharmaceuticals, patents, publicity...and philanthropy? Lancet 2009; 373(9665): 693.
11. Haas M, Ashton T, Blum K, et al. Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009; 92: 288-295
12. The Associated Press. CDC: 1 in 5 Americans vaccinated against swine flu. The New York Times, January 15, 2010.
13. Chaon A. France joins Europe in H1N1 vaccine sell-off. Agence France-Presse 2010.